PBH
PBH
NYSE · Pharmaceuticals

Prestige Consumer Healthcare

$42.98
-1.34 (-3.02%)
As of Nov 7, 1:35 AM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 7 70%
Hold 3 30%
Sell 0 0%
Price Target
Analyst Price Target +81.8% upside
Low Target $50.25
Average Target $78.15
High Target $108.25
Current Price $42.98
Current
$42.98
Target
$78.15
$50.25 $78.15 avg $108.25
Scenario Analysis
Bear Case
$50.25
16.9%
Low target
Base Case
$78.15
+81.8%
Avg target
Bull Case
$108.25
+151.9%
High target
Risk/Reward
9.0x
Highly favorable
Price in Context
52-Week High
$71.07
-39.5% from high
52-Week Low
$42.62
+0.8% from low
50-Day SMA
$48.16
-10.8% vs SMA
200-Day SMA
$53.64
-19.9% vs SMA
RSI (14)
35.2
Neutral
Target vs 52W High
$78.15
+10.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%